Tissium raises €60M for sutureless nerve repair

Paris-based medtech Tissium has raised €60M (a €30M Series D2 round plus a €30M EIB credit line) to commercialize COAPTIUM CONNECT, the only FDA-cleared sutureless nerve repair system. Instead of stitching severed nerves with needles, the device uses a 3D-printed chamber and a light-cured synthetic polymer to seal nerve ends without penetrating tissue. A 12-patient study showed 100% recovery of full movement with no pain at one year. The product launched in the US in November 2025. Tissium competes in a peripheral nerve repair market worth $13.4bn in 2025, projected to reach $30.5bn by 2033, against incumbents like Axogen and Integra LifeSciences that still rely on donor tissue and sutures. The funding will support US commercial expansion and pipeline products including a hernia repair device.

Nguồn: https://thenextweb.com/news/tissium-60m-sutureless-nerve-repair-fda. 8sync News chỉ tóm tắt và dẫn link; bản quyền nội dung thuộc tác giả và nguồn gốc.

Đề xuất cho bạn

The Next Web05 phút7 giờ trước

Alan raises €480M led by Prosus at €5.5bn

French health insurtech Alan has raised €480M in a Series G round led by Prosus at a €5.5bn valuation, just three months after a previous €100M raise. The company, which now has over €1.2bn in total funding, is profitable in France, serves 1.1 million members, and posted €800M+ in ARR growing 53% year-on-year. Alan's pitch centers on 'prevention insurance' — bundling health cover, care navigation, and AI-driven health assistance into a single app to shift healthcare from reactive to proactive. The capital will fund expansion into new markets, deeper AI investment, and potential acquisitions. The deal is one of Europe's largest non-AI raises of 2025 and a rare bright spot for French tech amid declining startup funding.

#startupNguồn